Neurocrine Biosciences Inc (NASDAQ:NBIX), a prominent player in the biopharmaceutical industry, has recently witnessed a significant insider transaction.
Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and delivering therapies for rare genetic diseases, has recently witnessed a significant insider sell by one of its top executives.
Recent filings with the SEC have revealed that Todd Cleveland, a director of IES Holdings Inc (NASDAQ:IESC), has sold 10,150 shares of the company on December 11, 2023.
David Kelly, the Chief Operating Officer of Kforce Inc (NASDAQ:KFRC), has recently sold 5,000 shares of the company's stock, according to a Form 4 filed with the Securities and Exchange Commission.